Sign inJoin waitlistJoin the waitlist

BH

Bryan Hennessy

Medical Oncology

Credentials: · ·

History

Medical Oncology
Internal Medicine

Research

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer
Journal of Clinical Oncology · 2008 · 2,356 citations
Exploiting the PI3K/AKT pathway for cancer drug discovery
Review · Nature Reviews Drug Discovery · 2005 · First of 5 authors · 1,808 citations
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer
Cancer Cell · 2007 · 1,338 citations

Gordon Mills
68 papers
AG
Ana-Maria Gonzalez-Angulo
30 papers · 17 as a resident
Vicente Valero
17 papers
Gabriel Hortobagyi
16 papers
Orla Fitzpatrick
10 papers
AM
Adrian Murphy
9 papers
Aysegul Sahin
9 papers
MG
Megan Greally
9 papers
JN
Jarushka Naidoo
8 papers
Russell Broaddus
8 papers
EH
Emer Hanrahan
7 papers
Funda Meric-Bernstam
7 papers

Grants

MD Anderson Gynecologic SPORE for Uterine Cancers
National Cancer Institute · P50
Project lead · $1M · University of Tx Md Anderson Can Ctr
2010–2016

Clinical trials

Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer
Principal investigator · Completed · Phase 2
Cancer Trials Ireland
2020–2022
Phase II Study of Erlotinib, an EGFR Inhibitor in Metastatic EGFR-positive 'Triple Receptor-negative' Breast Cancer
Principal investigator · Terminated · Phase 2
M.D. Anderson Cancer Center
2008–2010